Addiction

Papers
(The H4-Index of Addiction is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Mitigating and learning from the impact of COVID‐19 infection on addictive disorders191
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)180
Association of the COVID‐19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019–20 data164
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis105
Gateway or common liability? A systematic review and meta‐analysis of studies of adolescent e‐cigarette use and future smoking initiation105
Expert appraisal of criteria for assessing gaming disorder: an international Delphi study100
Alcohol consumption during the COVID‐19 pandemic in Europe: a large‐scale cross‐sectional study in 21 countries96
African Americans now outpace whites in opioid‐involved overdose deaths: a comparison of temporal trends from 1999 to 201890
Mechanical Turk data collection in addiction research: utility, concerns and best practices89
Shifts in alcohol consumption during the COVID‐19 pandemic: early indications from Australia88
Drug checking services for people who use drugs: a systematic review80
Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross‐sectional study79
Associations between solitary drinking and increased alcohol consumption, alcohol problems, and drinking to cope motives in adolescents and young adults: a systematic review and meta‐analysis69
Heroin use cannot be measured adequately with a general population survey66
Treatment rates for alcohol use disorders: a systematic review and meta‐analysis64
A meta‐analysis of problem gambling risk factors in the general adult population62
Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration56
Causal mechanisms proposed for the alcohol harm paradox—a systematic review51
Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States50
Alcohol use in pregnancy and its impact on the mother and child49
COVID‐19, smoking, vaping and quitting: a representative population survey in England48
Global opioid agonist treatment: a review of clinical practices by country48
Changes in alcohol consumption associated with social distancing and self‐isolation policies triggered by COVID‐19 in South Australia: a wastewater analysis study48
Behaviour change techniques associated with smoking cessation in intervention and comparator groups of randomized controlled trials: a systematic review and meta‐regression47
Electronic cigarettes, nicotine use trends and use initiation ages among US adolescents from 1999 to 201846
The associations between prenatal cannabis use disorder and neonatal outcomes46
Lessons from the public health responses to the US outbreak of vaping‐related lung injury45
Alcohol use disorders and the brain45
Moderators of changes in smoking, drinking and quitting behaviour associated with the first COVID‐19 lockdown in England45
Similar countries, similar factors? Studying the decline of heavy episodic drinking in adolescents in Finland, Norway and Sweden42
Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?42
World Health Organization risk drinking level reductions are associated with improved functioning and are sustained among patients with mild, moderate and severe alcohol dependence in clinical trials 40
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA40
Text messaging interventions for reducing alcohol consumption among risky drinkers: systematic review and meta‐analysis40
The unique nature of public stigma toward non‐medical prescription opioid use and dependence: a national study38
Bidirectional effects between loneliness, smoking and alcohol use: evidence from a Mendelian randomization study37
Unknown population‐level harms of cannabis and tobacco co‐use: if you don't measure it, you can't manage it36
Alcohol control policy measures and all‐cause mortality in Lithuania: an interrupted time–series analysis36
Social norms as a predictor of smoking uptake among youth: a systematic review, meta‐analysis and meta‐regression of prospective cohort studies36
Emotion regulation in substance use disorders: a systematic review and meta‐analysis36
The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use36
Technology‐mediated just‐in‐time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review36
0.030091047286987